Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Palivizumab 50mg/0.5ml solution for injection vials |
| BNF code | 0503050A0AAACAC |
| Virtual Therapeutic Moiety | Palivizumab |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 0.500 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Palivizumab |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 100.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intramuscular |
| Dose Form | |
| Formulation | Solution for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Palivizumab 50mg/0.5ml solution for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.